Sunlight and Systems Biology in Seattle



By John Russell

Nov. 13, 2007 |  SEATTLE — On this Monday in July it is not raining in Seattle. Apparently this is typical in summer and contrary to the region’s dreary image. A record-setting heat wave had bikers and joggers out in force under bright sun. Inside the Institute for Systems Biology (ISB),  thirty or so “students” gathered for the first day of ISB’s intensive week-long introduction to systems biology course and I was one of them.

It was a diverse group, drawn heavily from academia. About half had Ph.D.s (or soon will) in something and their experience ranges from newbies and post-doc (several) to experienced researchers (somewhat fewer). The rest had varying backgrounds. Gautam Venkatesan, a Stanford University-trained economist with experience at Hewlett-Packard and a software startup, ended up asking many of the week’s most interesting questions. There was a high school biology teacher from Tacoma, a medical lab worker from Dubai, and, of course, a science journalist (someone has to drag down the curve).

It was also a decidedly international group. There were attendees from institutions in Sweden, Italy, Switzerland, Spain, Qatar, and the United States. For five days, we were immersed in the concepts and tools that comprise systems biology (SB). We tackled a lab experiment designed to put SB ideas and tools into practice — measuring, analyzing, developing a hypothesis, and then testing the hypothesis. By the end of the course, “Each student should be able to develop a research outline that could form the core of a systems-based grant application,” say course materials.

That seemed like a stretch for me, but not for more advanced participants. In fact, one attendee, Scott Berceli, has already done just that. Berceli is a vascular surgeon affiliated with the University of Florida who also has Ph.D. in chemical engineering.

“I attended the course with a specific purpose,” he said, “to realign some of my multidisciplinary research activities with some of latest concepts in systems biology. In particular, the discussion of gene regulatory networks, and mathematical approaches for solution of these complex systems, provided me an important step forward in re-tooling my ongoing research efforts.”

Systems Projects
No stranger to molecular biology, the course proved broadly useful to Berceli but perhaps more valuable were independent meetings with ISB founder Leroy Hood and other investigators at the ISB, which provided a cornerstone for an NIH/ NHLBI systems biology proposal Berceli submitted in September 2007.

Berceli’s ambitious proposal, “examines vascular remodeling through a multi-scale approach, conceptualizing the process of vascular adaptation as two parallel, but interconnected, processes. The global remodeling response is mediated through variations in the gene regulatory network, while the focality of lesion development is modulated through the dynamics of monocyte homing to regions of altered flow.”

My goal was more modest: to have a hands-on experience (lecture, lab, and informatics tools) that crystallized the ideas, goals, and future directions of systems biology. Berceli was part of my lab group, and his guidance helped ensure my unpracticed lab skill didn’t muck up our piece of the class experiment. Indeed one of the cornerstones of systems biology is multidisciplinary collaboration and the 3- and four-person lab groups we divided into delivered a bit of that experience.

No doubt ISB has many goals in offering the course. Planting SB project seeds was certainly one, and that’s happening to some degree as exemplified by Berceli’s grant proposal. A few attendees said they had “job interviews” lined up inside ISB during the week so clearly recruiting is also going on. Identifying possible collaborators is another objective. And, of course, just getting the systems biology word out is important. The cost is fairly modest, $2000 for corporate attendees and $750 for students and postdocs. (ISB waived tuition for me.)

The opportunity to directly interact with Hood and prominent ISB staff was clearly a big attraction. Hood kicked off the week with an hour-long discussion of systems medicine and offered his definition of systems biology (see ISB Is a Sure Cure, Bio•IT World, Aug. 2007). Hood’s vision is powerful and his track record impressive. He takes aim at biology’s past dependence on rote memorization and cites his early training as an undergraduate at CalTech. He had Richard Feynman for freshman physics and Linus Pauling for freshman chemistry. Nice lineage! Both emphasized conceptual clarity and quantitative approaches, says Hood, and that’s stuck with him — the essence of systems biology.

Hood along with Reudi Aebersold and Alan Aderem founded ISB in 2000 to help chart systems biology future. Since that time ISB has broken a good deal of new ground in systems biology (particularly in technology development), championed the cause of multi-disciplinary teams and approaches to solving biological questions, assembled a faculty of 12, grown to about 200 staff, and spun a few companies out to commercialize technologies developed there. Indeed, Hood’s often-repeated belief that new technology (instrumentation) is necessary to advance all sciences is a dominant theme at ISB.

Buoyed by Hood’s opening salvo, the real work of the course began. Most days had two components, class and lab (wet and informatics). We started promptly at 8:30 AM and finished around 4:30 PM. ISB staff provided lectures on all things SB, including proteomics, functional genomics, network analysis, modeling techniques, systems genetics, hypothesis generation and testing, etc. Much of the material is readily accessible, but instructors often dig deep and are generally willing to have follow-up discussions later.

SB in the Lab
The lab exercise is designed to demonstrate an SB approach. We attempted to learn how a salt-loving bacterium, Halobacterium NRC-1, responds to copper stress. We did some cell culturing, took samples at different times, extracted RNA, determined its quality, labeled it, ran the microarrays, processed the raw data, used informatics tools to store, visualize and analyze results, imported appropriate pathway data from public sources, developed a hypothesis, and tested the hypothesis. In other words, quite a bit.

Some of us (me) hadn’t pipetted since the days of mouth pipetting! One of us (not me) cleaned a slide before the sample was applied, wiping off the probes! Our slides, prepared by ISB, had the full set of the bacterium’s 2400 genes. Fortunately, we were repeating portions of an experiment ISB has previously published. And the ISB staff was well prepared for most contingencies. Perhaps most surprising was that most of our data turned out to be quite useable.

A fair amount of time and effort throughout the course was devoted to introducing basic informatics tools and, again, the range of familiarity with those tools varied widely among attendees. Each student was provided with a laptop in class, and ISB personnel were generally able to keep students on track though it was occasionally challenging.

ISB primarily uses open source tools, many of which have been developed by ISB. The institute uses a home-grown software framework called Gaggle Boss, into which individual software tools called — you guessed it — Geese are plugged. A researcher can move data fairly easily from one tool to another using Gaggle. A few of the tools we used included Cytoscape; R statistical environment; Data Matrix Viewer; and we imported data from the KEGG database.

The class tentatively identified two responses to stress including gene networks for a chelating agent and a membrane transport mechanism; we then confirmed the findings.

Course director John Aitchison emphasizes, “[The course] provides an overview of systems biology, including sufficient background to understand the strengths and limitations. Systems biology can do a lot of things, but it does not work miracles. Students [will] understand its possibilities, get a sense of the promise, get excited about it and, where possible, incorporate systems thinking and systems biology into their projects.”

Venkatesan was sufficiently inspired to subsequently enroll in a genomics and proteomics course at the University of Washington, Department of Genome Sciences. “I hope to work in industry,” he says. “The people at ISB are truly distinguished pioneers. It is difficult to overestimate the complexity of the data and methods that we are undertaking.” It’s not hard to imagine this ‘02 Stanford grad running a SB company and, of course, Berceli has high hopes for his grant.

On the final day, Hood again addressed the class. His broad opening and closing presentations served as bookends for our time at ISB. This time he also took considerable time to answer the class’s many questions — the crowning event on what was a very worthwhile week.
----------------------
Subscribe to Bio-IT World  magazine.

Email John Russell.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .